BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 13069869)

  • 21. Prothrombotic hemostatic abnormalities in patients with refractory malignant lymphoma presenting for autologous stem cell transplantation.
    Conlan MG; Haire WD; Kessinger A; Armitage JO
    Bone Marrow Transplant; 1991 Jun; 7(6):475-9. PubMed ID: 1873594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The relations between Hodgkin's and non-Hodgkin's lymphoma].
    Lennert K
    Arzneimittelforschung; 1987 Feb; 37(2A):255-9. PubMed ID: 3566873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Lyposomal form of doxorubicin hydrochloride lypodox in the treatment of lymphogranulomatosis and non-Hodgkin's lymphomas].
    Ponamareva OV; Kindzel'skiĭ LP; Kulik GI
    Lik Sprava; 2001; (1):112-7. PubMed ID: 15311711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Malignant lymphoma: monitoring of tumour status in 273 patients using a monoclonal antibody, 'B5', reacting with autologous erythrocytes.
    Bruce L; Hancock BW; Cawood L
    Eur J Cancer Clin Oncol; 1987 Jun; 23(6):719-22. PubMed ID: 3653191
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of serum free light chains in predicting HIV-associated non-Hodgkin lymphoma and Hodgkin's lymphoma and its correlation with antiretroviral therapy.
    Bibas M; Trotta MP; Cozzi-Lepri A; Lorenzini P; Pinnetti C; Rizzardini G; Angarano G; Caramello P; Sighinolfi L; Mastroianni CM; Mazzarello G; Di Caro A; Di Giacomo C; d'Arminio Monforte A; Antinori A;
    Am J Hematol; 2012 Aug; 87(8):749-53. PubMed ID: 22718364
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Thrombocytosis in patients with non-Hodgkin's lymphomas and Hodgkin's disease].
    Dwilewicz-Trojaczek J; Wieczorek J
    Pol Arch Med Wewn; 1997 Aug; 98(8):117-21. PubMed ID: 9508664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignant lymphomas (lymphoblastomas) medical aspects--pitfalls in diagnosis.
    BOLDT MH
    J Ky State Med Assoc; 1952 Apr; 50(4):150-2. PubMed ID: 14917911
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum hyaluronan is increased in malignant lymphoma.
    Hasselbalch H; Hovgaard D; Nissen N; Junker P
    Am J Hematol; 1995 Dec; 50(4):231-3. PubMed ID: 7485095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoglobulin profile in lymphomas.
    Kaur H; Sharma VK; Singh T
    J Assoc Physicians India; 1986 Jun; 34(6):457. PubMed ID: 3771497
    [No Abstract]   [Full Text] [Related]  

  • 30. [Lymphocytes in malignant lymphoma and other related diseases].
    Itoga T; Yamamoto H; Kunitake A
    Saishin Igaku; 1969 Aug; 24(8):1672-80. PubMed ID: 5395283
    [No Abstract]   [Full Text] [Related]  

  • 31. Nitroblue tetrazolium test in Hodgkin disease and other malignant lymphomas.
    Chang JC; Appleby J; Bennett JM
    Arch Intern Med; 1974 Mar; 133(3):401-3. PubMed ID: 4590440
    [No Abstract]   [Full Text] [Related]  

  • 32. [Nuclear lesions revealed by the electron microscope in the cells of malignant lymphomas in man].
    LEPLUS R; DEBRAY J; PINET J; BERNHARD W
    C R Hebd Seances Acad Sci; 1961 Dec; 253():2788-90. PubMed ID: 14464180
    [No Abstract]   [Full Text] [Related]  

  • 33. [Malignant lymphomas (non-Hodgkin's lymphomas and Hodgkin's disease) associated with infection by the human immunodeficiency virus. Study of 9 cases].
    Lozano-Molero M; Ribera JM; Nomdedeu B; Llebaría C; Campo E; Montserrat E; Rozman C
    Med Clin (Barc); 1989 Mar; 92(8):302-5. PubMed ID: 2716418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunohistochemical in situ demonstration of cytokines in Hodgkin and non-Hodgkin lymphoma].
    Müller H; Takeshita M; Krause J; Schuster K; Kikuchi M; Stutte HJ
    Verh Dtsch Ges Pathol; 1992; 76():164-8. PubMed ID: 1283251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody response to adenovirus E1b-derived synthetic peptides and serum levels of p53 in patients with gastrointestinal and other malignant lymphomas.
    Lähdeaho ML; Lehtinen T; Aine R; Hakala T; Lehtinen M
    J Med Virol; 1994 Aug; 43(4):393-6. PubMed ID: 7964649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Malignant lymphomas in Korea.
    Chi JG; Kim CW; Cho KJ; Lee SK
    J Korean Med Sci; 1987 Dec; 2(4):231-7. PubMed ID: 3268180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clusterin expression in malignant lymphomas: a survey of 266 cases.
    Saffer H; Wahed A; Rassidakis GZ; Medeiros LJ
    Mod Pathol; 2002 Nov; 15(11):1221-6. PubMed ID: 12429802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The treatment of malignant lymphoma; Hodgkin's disease and lymphosarcoma.
    HYNES JF
    Miss Valley Med J; 1956 Nov; 78(6):273-4. PubMed ID: 13369388
    [No Abstract]   [Full Text] [Related]  

  • 39. [Sedimentation rate of white cells in lympho- & reticulosarcoma & in malignant lymphogranuloma].
    BELLESIA L; LUSVARGHI E
    Minerva Med; 1958 Jul; 49(57-58):2856-61. PubMed ID: 13577584
    [No Abstract]   [Full Text] [Related]  

  • 40. [Blood copper and ceruloplasmin levels in hemolymphopathies. I. Malignant lymphoma].
    Tura S; Bernardi L; Baccarani M; Sanguinetti F; Branzi A
    G Clin Med; 1968 Nov; 49(11):1090-104. PubMed ID: 5757473
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.